INS and COVID-19: In a retrospective study of 562 individuals with and without diabetes, critically ill patients affected by COVID-19 spent significantly less time in the normal range of glucose levels (70–150 mg/dL) than non-COVID-19 individuals (44.4% vs. 68.5%), with a higher need of daily insulin dose [19].